In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
June 21st, 2011 | 29 | Yes |
Popular Name: (2R)-2-amino-3-(3,4-dichlorophenyl)-1-(4-quinazolin-4-ylpiperazin-1-yl)propan-1-one (2R)-2-amino-3-(3,4-dichlorophen…
None
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.93 | 9.94 | -58.05 | 3 | 6 | 1 | 77 | 431.347 | 4 | ↓ |
Mid Mid (pH 6-8) | 2.93 | 9.62 | -13.3 | 2 | 6 | 0 | 75 | 430.339 | 4 | ↓ |
Lo Low (pH 4.5-6) | 2.93 | 10.38 | -103.05 | 4 | 6 | 2 | 78 | 432.355 | 4 | ↓ |
Lo Low (pH 4.5-6) | 2.93 | 10.4 | -95.57 | 4 | 6 | 2 | 78 | 432.355 | 4 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
AKT1-2-E | RAC-alpha Serine/threonine-protein Kinase (cluster #2 Of 3), Eukaryotic | Eukaryotes | 51 | 0.35 | Binding ≤ 10μM |
AKT2-2-E | Serine/threonine-protein Kinase AKT2 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 433 | 0.31 | Binding ≤ 10μM |
AKT3-2-E | Serine/threonine-protein Kinase AKT3 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 485 | 0.30 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
AKT1_HUMAN | P31749 | Serine/threonine-protein Kinase AKT, Human | 51 | 0.35 | Binding ≤ 1μM |
AKT2_HUMAN | P31751 | Serine/threonine-protein Kinase AKT2, Human | 433 | 0.31 | Binding ≤ 1μM |
AKT3_HUMAN | Q9Y243 | Serine/threonine-protein Kinase AKT3, Human | 485 | 0.30 | Binding ≤ 1μM |
AKT1_HUMAN | P31749 | Serine/threonine-protein Kinase AKT, Human | 51 | 0.35 | Binding ≤ 10μM |
AKT2_HUMAN | P31751 | Serine/threonine-protein Kinase AKT2, Human | 433 | 0.31 | Binding ≤ 10μM |
AKT3_HUMAN | Q9Y243 | Serine/threonine-protein Kinase AKT3, Human | 485 | 0.30 | Binding ≤ 10μM |
Description | Species |
---|---|
Activation of BAD and translocation to mitochondria | |
Activation of PKB | |
AKT phosphorylates targets in the cytosol | |
AKT phosphorylates targets in the nucleus | |
AKT-mediated inactivation of FOXO1A | |
Butyrate Response Factor 1 (BRF1) destabilizes mRNA | |
CD28 dependent PI3K/Akt signaling | |
Constitutive PI3K/AKT Signaling in Cancer | |
CTLA4 inhibitory signaling | |
deactivation of the beta-catenin transactivating complex | |
Downregulation of ERBB2:ERBB3 signaling | |
eNOS activation | |
G beta:gamma signalling through PI3Kgamma | |
GPVI-mediated activation cascade | |
Inhibition of TSC complex formation by PKB | |
Integrin alphaIIb beta3 signaling | |
KSRP destabilizes mRNA | |
Negative regulation of the PI3K/AKT network | |
PDE3B signalling | |
PIP3 activates AKT signaling | |
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | |
Translocation of GLUT4 to the plasma membrane | |
VEGFR2 mediated vascular permeability |
No pre-computed analogs available. Try a structural similarity search.